Concepedia

Xiaoling Luo

XL

Statistics

Publications

20

Citations

888

H-Index

17

Active since

2004

Affiliations

Tumor Hospital of Guangxi Medical University(Current)

Guangxi Medical University

Fudan University

Sun Yat-sen University

Second Military Medical University

Xiaoling Luo is an author at Tumor Hospital of Guangxi Medical University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2004–2025

20

Publications

20

Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma

Jin Hou, Ye Zhou, Yuanyuan Zheng et al. · Cancer Cell · 2013 · 231 citations · Full text

, , +16

Micro<scp>RNA</scp>‐486‐5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1

Xinping Huang, Jin Hou, Xiaoyun Shen et al. · FEBS Journal · 2014 · 88 citations · Full text

, , +17

Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway

Xiaoyun Shen, Yong Zhang, Yan Feng et al. · International Journal of Oncology · 2014 · 62 citations · Full text

, , +17

Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma

Jiaxiang Ye, Jinyan Zhang, Yufeng Lv et al. · Journal of Cellular Biochemistry · 2019 · 60 citations

, , +17

MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma

Manya Wu, Chao‐Yuan Huang, Xinping Huang et al. · Oncology Reports · 2017 · 50 citations · Full text

, , +17

1–5 of 20